HFEPX · Eval paper review
Praveen Reddy, Charuta Mandke, Suvrankar Datta, Sarah Khan +3 more
Published
Aug 12, 2026
Citations
0
Trust level
High
Usefulness score
77/100 (High)
Extraction confidence
80% (High)
Derived from extracted protocol signals and abstract evidence.
Rater population
Domain Experts
Signals refreshed
Aug 12, 2026
This paper has strong direct human-feedback and evaluation protocol signal and is suitable as a primary eval pipeline reference.
Use this as a practical starting point for protocol research, then validate against the original paper.
Best use
Primary protocol reference for eval design
Use if you need
A benchmark-and-metrics comparison anchor.
What to verify
Validate the evaluation procedure and quality controls in the full paper before operational use.
Main weakness
No major weakness surfaced.
Use this as a primary source when designing or comparing eval protocols.
If you are doing eval pipeline work, start here
General-purpose large language models (LLMs) have recently been reported to match or exceed specialized clinical AI tools on medical benchmarks, but such comparisons draw on a narrow set of systems and on benchmarks developed largely in high-income settings. We evaluate VITA, a retrieval-augmented generation (RAG) system purpose-built for contextual knowledge retrieval in India and other low- and middle-income (LMIC) settings. VITA retrieves from a curated corpus of disease-specific guidelines, India-specific antimicrobial resistance data, national formulary constraints, and resource-limited care protocols; its architecture and corpus are proprietary, but the benchmark, the physician-written rubrics, and our full response and scoring outputs are public for independent verification. On 4,023 English-language HealthBench questions (80.5% of the benchmark), scored with a GPT-4.1 judge, VITA ranked first with 51.9% of possible rubric points, ahead of GPT-5.4 (46.1%), o4-mini (44.3%), Gemini 3.1 Pro (42.6%), and Claude Sonnet 4.6 (37.3%), and scored highest on 45.4% of questions. To test robustness to newer models and judge lineage, a 500-question subset was re-run against current-generation models (GPT-5.5, Claude Opus 4.8, Gemini 3.5 Pro, Grok 4.3) and graded by a neutral open-weight judge (DeepSeek-V4-Pro) sharing no lineage with any system tested. Here the gap narrowed to parity: VITA and GPT-5.5 were statistically indistinguishable on mean per-question score, while VITA led on points-weighted score and won the most questions. VITA's advantages in accuracy and completeness persisted under the neutral judge; its communication scores were lower. These results indicate that a purpose-built clinical RAG system remains competitive with frontier LLMs on an open benchmark, consistent with corpus specificity as a design variable that improves grounding at some cost to communication polish.
These are the protocol signals we could actually recover from the available paper metadata. Use them to decide whether this paper is worth deeper reading.
Rubric Rating
Directly usable for protocol triage.
"General-purpose large language models (LLMs) have recently been reported to match or exceed specialized clinical AI tools on medical benchmarks, but such comparisons draw on a narrow set of systems and on benchmarks developed largely in high-income settings."
Llm As Judge, Automatic Metrics
Includes extracted eval setup.
"General-purpose large language models (LLMs) have recently been reported to match or exceed specialized clinical AI tools on medical benchmarks, but such comparisons draw on a narrow set of systems and on benchmarks developed largely in high-income settings."
Not reported
No explicit QC controls found.
"General-purpose large language models (LLMs) have recently been reported to match or exceed specialized clinical AI tools on medical benchmarks, but such comparisons draw on a narrow set of systems and on benchmarks developed largely in high-income settings."
Healthbench
Useful for quick benchmark comparison.
"On 4,023 English-language HealthBench questions (80.5% of the benchmark), scored with a GPT-4.1 judge, VITA ranked first with 51.9% of possible rubric points, ahead of GPT-5.4 (46.1%), o4-mini (44.3%), Gemini 3.1 Pro (42.6%), and Claude Sonnet 4.6 (37.3%), and scored highest on 45.4% of questions."
Accuracy
Useful for evaluation criteria comparison.
"VITA's advantages in accuracy and completeness persisted under the neutral judge; its communication scores were lower."
Domain Experts
Helpful for staffing comparability.
"General-purpose large language models (LLMs) have recently been reported to match or exceed specialized clinical AI tools on medical benchmarks, but such comparisons draw on a narrow set of systems and on benchmarks developed largely in high-income settings."
General-purpose large language models (LLMs) have recently been reported to match or exceed specialized clinical AI tools on medical benchmarks, but such comparisons draw on a narrow set of systems and on benchmarks developed largely in high-income settings.
Based on abstract + metadata only. Check the source paper before making high-confidence protocol decisions.
Human feedback protocol is explicit
Detected: Rubric Rating
Evaluation mode is explicit
Detected: Llm As Judge, Automatic Metrics
Quality control reporting appears
No calibration/adjudication/IAA control explicitly detected.
Benchmark or dataset anchors are present
Detected: Healthbench
Metric reporting is present
Detected: accuracy
